Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study.
Cerebral white matter disease in patients with malignancy: pml versus toxic leucoencephalopathy due to chemotherapy.
A novel activity for fungal nitronate monooxygenase: Detoxification of the metabolic inhibitor propionate-3-nitronate.
Nigella sativa amliorates inflammation and demyelination in the experimental autoimmune encephalomyelitis-induced Wistar rats.
Comparing two conditions of administering the six-minute walk test in people with multiple sclerosis.
Participation of interleukin 17A in neuroimmune interactions.
Training of Respiratory Muscles in Patients With Multiple Sclerosis: A Systematic Review.
Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex(R)) in people with multiple sclerosis: a new approach.
Targeted inhibition of complement using complement receptor 2-conjugated inhibitors attenuates EAE.
Accuracy of routine fat-suppressed FLAIR and diffusion-weighted images in detecting clinically evident optic neuritis.
Vitamin D and multiple sclerosis.
Anti-interleukin-2 receptor alpha for multiple sclerosis?
Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis.
MS565: A SPECT Tracer for Evaluating the Brain Penetration of BAF312 (Siponimod).
Acute disseminated encephalomyelitis, transverse myelitis, and neuromyelitis optica.
Management of disease modifying treatments in neurological autoimmune diseases of the central nervous system.
Contrast enrichment of spinal cord MR imaging using a ratio of T1-weighted and T2-weighted signals.
Human pluripotent stem cell-derived neural constructs for predicting neural toxicity.
Early and Degressive Putamen Atrophy in Multiple Sclerosis.
Astrocytes Promote Oligodendrogenesis after White Matter Damage via Brain-Derived Neurotrophic Factor.
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica.
[Ultrahigh field MRI in context of neurological diseases.]
Therapeutic satisfaction and subjective effects of different strains of pharmaceutical-grade cannabis.
Antigenic peptide molecular recognition by the DRB1-DQB1 haplotype modulates multiple sclerosis susceptibility.
Progressive Increase of T1 Signal Intensity of the Dentate Nucleus on Unenhanced Magnetic Resonance Images Is Associated With Cumulative Doses of Intravenously Administered Gadodiamide in Patients With Normal Renal Function, Suggesting Dechelation.
Pages
« first
‹ previous
…
347
348
349
350
351
352
353
354
355
…
next ›
last »